Opthea Ltd ADR (CKDXY_old)

NASDAQ
11.2
0.0(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    11.1 - 11.2

CKDXY_old Overview

Prev. Close
10.2
Day's Range
11.1-11.2
Revenue
-
Open
11.1
52 wk Range
10.2-11.2
EPS
-
Volume
0
Market Cap
419.04M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
24.44%
Shares Outstanding
-
Next Earnings Date
-
What is your sentiment on Opthea Ltd ADR?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyBuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Opthea Ltd ADR Company Profile

Opthea Ltd ADR Company Profile

Employees
0
Market
Australia

Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia. The company’s development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3 for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.